Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Ranieri

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2009
CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)Maddalena Gigante, Paola Pontrelli, Eustacchio Montemurno, et al.
Free Radical Biology & Medicine|December 5, 2013
Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injuryGiuseppe Stefano Netti, Clelia Prattichizzo, Eustacchio Montemurno, et al.
Urologic Oncology|May 3, 2008
Current insights in renal cell cancer pathologyVito Mancini, Michele Battaglia, Pasquale Ditonno, et al.
Scientific Reports|May 28, 2024
PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patientsGiuseppe Castellano, Giuseppe Stefano Netti, Vincenzo Cantaluppi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patientsMargherita Gigante, Maja Mandic, Amy K Wesa, et al.
Indian Journal of Pediatrics|September 30, 2023
Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS)Luisa Santangelo, Giuseppe Stefano Netti, Sebastiano Mazza, et al.
Blood Purification|January 30, 2022
Therapeutic Approach for Recurrent Focal Segmental Glomerulosclerosis in Pediatric Renal Transplant Recipients: A Single-Center ExperienceDiletta Domenica Torres, Giulia Fontò, Luca Guastamacchia, et al.
Cells|September 28, 2021
Role of Complement in Regulating Inflammation Processes in Renal and Prostate CancersGiuseppe Stefano Netti, Rossana Franzin, Alessandra Stasi, et al.
The New England Journal of Medicine|April 1, 2005
Sirolimus for Kaposi's sarcoma in renal-transplant recipientsGiovanni Stallone, Antonio Schena, Barbara Infante, et al.
Cancer Research|August 9, 2003
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinomaTomohide Tatsumi, Christopher J Herrem, Walter C Olson, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2009
CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)Maddalena Gigante, Paola Pontrelli, Eustacchio Montemurno, et al.
Free Radical Biology & Medicine|December 5, 2013
Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injuryGiuseppe Stefano Netti, Clelia Prattichizzo, Eustacchio Montemurno, et al.
Urologic Oncology|May 3, 2008
Current insights in renal cell cancer pathologyVito Mancini, Michele Battaglia, Pasquale Ditonno, et al.
Scientific Reports|May 28, 2024
PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patientsGiuseppe Castellano, Giuseppe Stefano Netti, Vincenzo Cantaluppi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patientsMargherita Gigante, Maja Mandic, Amy K Wesa, et al.
Indian Journal of Pediatrics|September 30, 2023
Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS)Luisa Santangelo, Giuseppe Stefano Netti, Sebastiano Mazza, et al.
Blood Purification|January 30, 2022
Therapeutic Approach for Recurrent Focal Segmental Glomerulosclerosis in Pediatric Renal Transplant Recipients: A Single-Center ExperienceDiletta Domenica Torres, Giulia Fontò, Luca Guastamacchia, et al.
Cells|September 28, 2021
Role of Complement in Regulating Inflammation Processes in Renal and Prostate CancersGiuseppe Stefano Netti, Rossana Franzin, Alessandra Stasi, et al.
The New England Journal of Medicine|April 1, 2005
Sirolimus for Kaposi's sarcoma in renal-transplant recipientsGiovanni Stallone, Antonio Schena, Barbara Infante, et al.
Cancer Research|August 9, 2003
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinomaTomohide Tatsumi, Christopher J Herrem, Walter C Olson, et al.
Pageof 13